These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28326884)

  • 1. Oral rather than intravenous corticosteroids should be used to treat MS relapses - Yes.
    Le Page E; Edan G
    Mult Scler; 2017 Jul; 23(8):1056-1058. PubMed ID: 28326884
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral rather than intravenous corticosteroids should be used to treat MS relapses - No.
    Bowen JD; Qian P
    Mult Scler; 2017 Jul; 23(8):1058-1060. PubMed ID: 28326883
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis.
    De Keyser J; Zwanikken C
    Lancet; 1997 Jun; 349(9066):1696; author reply 1697. PubMed ID: 9186398
    [No Abstract]   [Full Text] [Related]  

  • 4. Would it be recommended treating multiple sclerosis relapses with high dose oral instead intravenous steroids during the COVID-19 pandemic? Yes.
    Segamarchi C; Silva B; Saidon P; Garcea O; Alonso R
    Mult Scler Relat Disord; 2020 Nov; 46():102449. PubMed ID: 32853893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of corticosteroids in multiple sclerosis by consultant neurologists in the United Kingdom.
    Tremlett HL; Luscombe DK; Wiles CM
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):362-5. PubMed ID: 9728950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosteroids in the treatment of multiple sclerosis.
    Myhr KM; Mellgren SI
    Acta Neurol Scand Suppl; 2009; (189):73-80. PubMed ID: 19566504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis.
    de Seze J; Chapelotte M; Delalande S; Ferriby D; Stojkovic T; Vermersch P
    Mult Scler; 2004 Oct; 10(5):596-7. PubMed ID: 15471379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral versus intravenous steroids in multiple sclerosis relapses - a perennial question?
    Chataway J
    Mult Scler; 2014 May; 20(6):643-5. PubMed ID: 24756993
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronotherapy using corticosteroids for multiple sclerosis relapses.
    Glass-Marmor L; Paperna T; Ben-Yosef Y; Miller A
    J Neurol Neurosurg Psychiatry; 2007 Aug; 78(8):886-8. PubMed ID: 17056624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current therapy of multiple sclerosis--high-dose intravenous therapy with corticosteroids].
    Voltz R; Hohlfeld R
    Nervenarzt; 1992 Dec; 63(12):773-5. PubMed ID: 1494395
    [No Abstract]   [Full Text] [Related]  

  • 11. Corticosteroids in the management of acute multiple sclerosis exacerbations.
    Smets I; Van Deun L; Bohyn C; van Pesch V; Vanopdenbosch L; Dive D; Bissay V; Dubois B;
    Acta Neurol Belg; 2017 Sep; 117(3):623-633. PubMed ID: 28391390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Megadose corticosteroids in multiple sclerosis.
    Kupersmith MJ; Kaufman D; Paty DW; Ebers G; McFarland H; Johnson K; Reingold S; Whitaker J
    Neurology; 1994 Jan; 44(1):1-4. PubMed ID: 8290041
    [No Abstract]   [Full Text] [Related]  

  • 13. Corticosteroids treatment.
    Pozzilli C; Marinelli F; Romano S; Bagnato F
    J Neurol Sci; 2004 Aug; 223(1):47-51. PubMed ID: 15261560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose oral steroids commonly used to treat relapses in Canadian MS clinics.
    Morrow SA; Metz LM; Kremenchutzky M
    Can J Neurol Sci; 2009 Mar; 36(2):213-5. PubMed ID: 19378717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cortisol suppression in corticoid therapy. Comments on the contribution by R. Voltz and R. Hohlfeld. Current therapy of multiple sclerosis--high-dose intravenous therapy with corticosteroids].
    Haupts M; Schlüter T; Gehlen W
    Nervenarzt; 1993 Jun; 64(6):413. PubMed ID: 8332236
    [No Abstract]   [Full Text] [Related]  

  • 16. Is the Choosing Wisely
    Trumbic B; Zéphir H; Ouallet JC; Le Page E; Laplaud D; Bensa C; de Sèze J
    Rev Neurol (Paris); 2018; 174(1-2):28-35. PubMed ID: 29128151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral or intravenous methylprednisolone for acute relapses of MS?
    Barkhof F; Polman C
    Lancet; 1997 Mar; 349(9056):893-4. PubMed ID: 9093245
    [No Abstract]   [Full Text] [Related]  

  • 18. Introducing high dose steroid therapy for MS relapses into the community.
    Cassia B; Ranford-Mills M
    Br J Community Nurs; 2010 Jan; 15(1):28-31. PubMed ID: 20216516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Corticosteroid therapy in multiple sclerosis. Comment on the letter by M. Haupts et al].
    Hohlfeld R; Engelhardt D
    Nervenarzt; 1994 Feb; 65(2):148. PubMed ID: 8164771
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis.
    Tremlett H
    Lancet; 1997 Jun; 349(9066):1696-7. PubMed ID: 9186400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.